Alzheimer’s therapy: scents vs nonsense
October 25, 2013 | James Kohl
Scent and the City By LANCE HOSEY Published: October 25, 2013 in the New York Times
Excerpt: In 2009, medical researchers at Tottori University in Japan found that exposing Alzheimer’s patients to rosemary and lemon in the morning and lavender and orange in the evening resulted in improved cognitive functions. A 2006 study by researchers at the New York University Medical Center discovered that postoperative patients exposed to the smell of lavender reported a higher satisfaction rate with pain control. And a 2007 study in the Journal of Clinical Oncology reported that cancer patients who received massage with aromatic oils experienced a significant improvement in anxiety and depression.
My comment: Given reports like these and more than 650 blog posts here that attest to the overwhelming impact of olfactory/pheromonal input on adaptive behaviors, it surprises me how few people seem to recognize what I am trying to convey about epigenetic cause and effect. Simply put, if you listen to the evolutionary theorists and human ethologists who have not learned anything about biology in the past several decades, you are among those who enable the suffering to continue for families affected by neurodegenerative diseases, like Alzheimer’s. If not for their staunchly defended opinions about mutation-initiated natural selection by theorists, scientific progress by biologists and physiologists might well have led to additional interest in the alleviation of suffering via the study of Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis.